Skip to main content

Atrial Flutter clinical trials at UCSF

2 in progress, 1 open to eligible people

Showing trials for
  • Prospective Observational Cohort Study of Fetal Atrial Flutter & Supraventricular Tachycardia

    open to eligible females ages 16-50

    The FAST Trial Registry is a prospective observational cohort study of fetuses with a new diagnosis of atrial flutter (AF) or supraventricular tachycardia (SVT) that is severe enough to consider prenatal treatment (see eligibility criteria below). Aims of the Registry include to establish a large clinical database to determine and compare the efficacy and safety of different prenatal treatment strategies including observation without immediate treatment, transplacental antiarrhythmic fetal treatment and direct fetal treatment from the time of tachycardia diagnosis to death, neonatal hospital discharge or to a maximum of 30 days after birth.

    San Francisco, California and other locations

  • Wire Instrumentation Using Radiofrequency Energy to Impact Transseptal Efficiency

    Sorry, in progress, not accepting new patients

    This is a randomized controlled trial examining whether Baylis's Versacross RF wire versus the conventional Baylis RF needle is better at puncturing through a thin wall in the heart (called "transseptal puncture") as measured by time to successful transseptal puncture, during cardiac ablation procedures.

    San Francisco, California

Our lead scientists for Atrial Flutter research studies include .